Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semuloparin Dose Response in TKR (TREK)
NCT00331838Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Jun 2007
- Modality
- Peptides, Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of semuloparin in venous thromboembolism (VTE), sponsored by Sanofi. Started May 2006; status: completed.
02
Drugs
semuloparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00331838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331838.